Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4792 | 1652 | 30.3 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2095 | 4737 | AUTOIMMUNE PANCREATITIS//INFLAMMATORY PSEUDOTUMOR//INFLAMMATORY MYOFIBROBLASTIC TUMOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AUTOIMMUNE PANCREATITIS | Author keyword | 1233 | 89% | 33% | 549 |
2 | IGG4 RELATED DISEASE | Author keyword | 395 | 83% | 14% | 225 |
3 | IGG4 | Author keyword | 270 | 54% | 21% | 351 |
4 | MIKULICZS DISEASE | Author keyword | 111 | 88% | 3% | 52 |
5 | LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS | Author keyword | 99 | 97% | 2% | 29 |
6 | IGG4 RELATED SCLEROSING DISEASE | Author keyword | 80 | 78% | 3% | 53 |
7 | IGG4 RELATED SCLEROSING CHOLANGITIS | Author keyword | 72 | 93% | 2% | 27 |
8 | IGG4 RELATED SYSTEMIC DISEASE | Author keyword | 65 | 93% | 2% | 25 |
9 | HLTH SAFETY ENVIRONM MANAGEMENT | Address | 62 | 68% | 3% | 54 |
10 | IMMUNOGLOBULIN G4 | Author keyword | 61 | 67% | 3% | 55 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SCLEROSING PANCREATITIS | 474 | 84% | 16% | 260 |
2 | AUTOIMMUNE PANCREATITIS | 417 | 58% | 29% | 483 |
3 | SERUM IGG4 | 372 | 90% | 10% | 159 |
4 | LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS | 308 | 92% | 7% | 120 |
5 | SERUM IGG4 CONCENTRATIONS | 144 | 98% | 2% | 39 |
6 | SCLEROSING DISEASE | 130 | 77% | 5% | 88 |
7 | IMMUNOGLOBULIN G4 ASSOCIATED CHOLANGITIS | 106 | 82% | 4% | 61 |
8 | IGG4 POSITIVE PLASMA CELLS | 102 | 85% | 3% | 53 |
9 | MIKULICZS DISEASE | 102 | 76% | 4% | 72 |
10 | IGG4 CONCENTRATIONS | 102 | 100% | 2% | 30 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MECHANISMS OF DISEASE IgG4-Related Disease | 2012 | 328 | 83 | 83% |
Consensus statement on the pathology of IgG4-related disease | 2012 | 244 | 60 | 98% |
IgG4-related kidney disease - an update | 2015 | 4 | 50 | 94% |
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details | 2012 | 121 | 57 | 98% |
IgG4-related disease | 2015 | 3 | 88 | 95% |
IgG4-Related Disease | 2014 | 22 | 133 | 62% |
IgG4-related kidney disease | 2014 | 13 | 28 | 96% |
IgG4-related Sclerosing Disease A Critical Appraisal of an Evolving Clinicopathologic Entity | 2010 | 143 | 165 | 82% |
IgG4-Related Ophthalmic Disease. Part I: Background and Pathology | 2015 | 2 | 54 | 91% |
IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects | 2015 | 2 | 54 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HLTH SAFETY ENVIRONM MANAGEMENT | 62 | 68% | 3.3% | 54 |
2 | COMMUNITY BASED MED EDUC | 12 | 52% | 1.0% | 17 |
3 | ENDOSCOP EXAMINAT | 7 | 57% | 0.5% | 8 |
4 | ACUPUNCTURE MOXIBUS | 4 | 75% | 0.2% | 3 |
5 | GASTROENTEROL ENDOCRINOL METAB INFECTIOL | 3 | 60% | 0.2% | 3 |
6 | UNIT MED CLIN IMMUNOL | 2 | 32% | 0.4% | 6 |
7 | OXFORD NIHR BRC | 2 | 67% | 0.1% | 2 |
8 | EXCELLENCE THYROID CARE | 2 | 27% | 0.4% | 7 |
9 | HEPAT BILIARY PANCREAT MED | 2 | 50% | 0.2% | 3 |
10 | GASTROENTEROL RHEUMATOL CLIN IMMUNOL | 2 | 22% | 0.5% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000144788 | RETROPERITONEAL FIBROSIS//IDIOPATHIC RETROPERITONEAL FIBROSIS//RIEDELS THYROIDITIS |
2 | 0.0000083393 | PACHYMENINGITIS//HYPERTROPHIC PACHYMENINGITIS//HYPERTROPHIC CRANIAL PACHYMENINGITIS |
3 | 0.0000070966 | PRIMARY SCLEROSING CHOLANGITIS//SCLEROSING CHOLANGITIS//NORWEGIAN PSC |
4 | 0.0000063940 | DRUG INDUCED PANCREATITIS//SECT UPPER GASTROINTESTINAL SURG//BILIARY STONE |
5 | 0.0000053823 | INFLAMMATORY PSEUDOTUMOR//INFLAMMATORY MYOFIBROBLASTIC TUMOR//PLASMA CELL GRANULOMA |
6 | 0.0000052970 | ENDOSCOPIC ULTRASOUND//EUS FNA//ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION |
7 | 0.0000051373 | CALCIFYING FIBROUS PSEUDOTUMOR//CALCIFYING FIBROUS TUMOR//CALCIFYING FIBROUS PSEUDOTUMOUR |
8 | 0.0000047692 | CHRONIC PANCREATITIS//HEREDITARY PANCREATITIS//PRSS1 |
9 | 0.0000046881 | TOLOSA HUNT SYNDROME//PAINFUL OPHTHALMOPLEGIA//ORBITAL MYOSITIS |
10 | 0.0000044062 | EOSINOPHILIC ANGIOCENTRIC FIBROSIS//GRANULOMA FACIALE//ERYTHEMA ELEVATUM DIUTINUM |